Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 5Recruiting 4Terminated 3Withdrawn 2Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 3Lymphoid 3Myeloid 2Thoracic 1Plasma cell 1Other neoplasm 1Head & Neck 1Gynecologic 1Gastrointestinal 1Endocrine 1CNS 1

Conditions

Glioblastoma 82Brain Neoplasms 79Glioma 63Neoplasms 16Neuroblastoma 15Meningioma 14Medulloblastoma 13Neurofibromatosis 1 10Ependymoma 10Meningeal Carcinomatosis 9Carcinoma, Non-Small-Cell Lung 9Breast Neoplasms 8Neurologic Manifestations 6Diffuse Intrinsic Pontine Glioma 6Astrocytoma 6Spinal Cord Neoplasms 5Recurrence 5Central Nervous System Neoplasms 5Pheochromocytoma 4Paraganglioma 4Oligodendroglioma 4Lung Neoplasms 4Sarcoma 3Rhabdoid Tumor 3Pancreatic Neoplasms 3Ovarian Neoplasms 3Neuroma, Acoustic 3Neurofibroma, Plexiform 3Head and Neck Neoplasms 3Ganglioneuroblastoma 3

Interventions

trametinib 1dabrafenib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Lymphoproliferative Disorders × CNS × Clear all
NCT07440290 2026-02-27

DETERMINE

Cancer Research UK

Phase 2/3 Not yet recruiting
30 enrolled
CNSEndocrineGastrointestinalGynecologicHead & NeckLymphoidMyeloidOther hematologic neoplasmPlasma cellThoracic

Thyroid Cancer, Papillary, Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms, Glioma, Histiocytosis, Langerhans-Cell, Laryngeal Neoplasms, Lymphoproliferative Disorders, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Ovarian Neoplasms, Colorectal Neoplasms, Hematologic Neoplasms, Erdheim-Chester Disease, Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡